Edition:
United Kingdom

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.93USD
19 Jan 2018
Change (% chg)

$-0.15 (-7.21%)
Prev Close
$2.08
Open
$2.04
Day's High
$2.06
Day's Low
$1.92
Volume
122,330
Avg. Vol
68,279
52-wk High
$6.56
52-wk Low
$1.45

Select another date:

Wed, Jan 17 2018

BRIEF-Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology

* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY

BRIEF-Neurometrix Reports Preliminary 2017 Financial Highlights

* NEUROMETRIX INC - PRELIMINARY GAAP REVENUE FOR Q4 OF 2017 IS ESTIMATED AT APPROXIMATELY $4.9 MILLION IN COMPARISON WITH $3.7 MILLION IN Q4 2016 Source text for Eikon: Further company coverage:

BRIEF-NeuroMetrix CFO reports purchase of 2,500 shares of co's common stock on Oct 23 at $1.77 per share

* NeuroMetrix Inc CFO Thomas​ ‍Higgins reports purchase of 2,500 shares of co's common stock on Oct 23 at $1.77 per share - sec filing Source text (http://bit.ly/2gBQZj2) Further company coverage:

BRIEF-NeuroMetrix files for resale of up to 2.7 mln shares of its stock‍​

* NeuroMetrix files for resale of up to 2.7 million shares of co's common stock issuable upon conversion of shares of series F preferred stock - sec filing‍​ Source text: (http://bit.ly/2un1wUY) Further company coverage:

BRIEF-Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan

* Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan Source text for Eikon: Further company coverage:

Select another date: